Akron Biotech Expanding to New, State-of-the-Art Biotechnology Facility

Move Will Enable Akron R&D and Manufacturing to Meet Growing Demand for

Regenerative Medicine Products and Increasing Quality Standards

BOCA RATON, Fla.--()--Akron Biotechnology, LLC (Akron Biotech), which provides novel technologies for cell therapy and regenerative medicine discovery, development, and commercialization, today announced its expansion and move to a new, larger facility. Akron will continue to be headquartered in Boca Raton, FL, while significantly increasing space for its R&D and manufacturing operations.

“The expansion will play an increasingly important role in the company’s growth and allow Akron to more strongly meet the growing demand for validated products and processes for the regenerative medicine industry,” said Claudia Zylberberg, PhD, Founder and CEO of Akron Biotech. “Our commitment to providing our customers with quality products and comprehensive solutions to meet their specific needs has resulted in consistent growth, making Akron a key player in the regenerative medicine/biotechnology arena.”

While the company's headquarters and operations have already moved to the new physical address, the construction of its new state-of-the-art biotechnology facility is still under way. Once completed, the facility will house over 12,000 sq. ft. of laboratory and manufacturing space. It will focus on the translation and commercialization of innovative discoveries as well as manufacturing for both research and clinical use.

Akron's new facility will be one of the largest of its kind in Florida and will produce regulated products on a large scale for academic and industry clients from both the U.S. and abroad. The facility will enhance the company’s current capacity with several class 10,000 and class 100 clean rooms -- which will accommodate small and large scale manufacturing -- and cell culture labs for bioassay development and validation.

The augmented capacity will further expand Akron's proven expertise in cGMP product manufacturing and process development, providing its customers with greater flexibility in manufacturing and enhanced environmental control as well as increased support for documentation and compliance.

About Akron Biotech

As an ISO certified global supplier, Akron Biotech manufactures ancillary materials and provides novel technologies for cell therapy and regenerative medicine discovery, development, and commercialization, meeting the industry’s quality standards worldwide. Akron Biotech has a strategic focus on delivering biological materials, technologies, and services for the regenerative medicine industry. For more information please visit www.akronbiotech.com.

Contacts

Akron Biotechnology, LLC
Sonia I. Suarez, 561-750-6120
ssuarez@akronbiotech.com

Release Summary

Akron Biotech announced its expansion to a new, larger facility with 12,000 sq. ft. of laboratory and manufacturing space, focusing on commercialization for both research and clinical use.

Contacts

Akron Biotechnology, LLC
Sonia I. Suarez, 561-750-6120
ssuarez@akronbiotech.com